ClearBridge LLC (Maryland)’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-148,600
Closed -$4.79M – 186
2015
Q4
$4.79M Buy
148,600
+5,390
+4% +$175K 0.09% 117
2015
Q3
$4.63M Buy
143,210
+14,640
+11% +$551K 0.09% 116
2015
Q2
$5.32M Sell
128,570
-23,220
-15% -$979K 0.1% 109
2015
Q1
$6.82M Hold
151,790
– – 0.12% 99
2014
Q4
$5.68M Hold
151,790
– – 0.1% 110
2014
Q3
$5.3M Hold
151,790
– – 0.1% 111
2014
Q2
$5.36M Hold
151,790
– – 0.1% 113
2014
Q1
$4.95M Hold
151,790
– – 0.09% 107
2013
Q4
$6.39M Hold
151,790
– – 0.12% 103
2013
Q3
$6.05M Hold
151,790
– – 0.12% 99
2013
Q2
$6.28M Buy
+151,790
New +$6.15M 0.11% 118

Other funds holding HAE

ClearBridge LLC (Maryland)'s HAE Position: Q1 2016 in Review

ClearBridge LLC (Maryland) sold out of Haemonetics (HAE) in Q1 2016, closing a stake of 148,600 shares — an estimated $4.79M sold.

ClearBridge LLC (Maryland) first reported a position in HAE in Q2 2013 and held it in 11 quarters. The position peaked at $6.82M in Q1 2015. 171 funds tracked by Wall St. Rank hold HAE as of Q1 2016.

  • ClearBridge LLC (Maryland) reported no remaining Haemonetics position as of Q1 2016 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 148,600 Haemonetics shares in Q1 2016, an estimated $4.79M.
  • ClearBridge LLC (Maryland) first reported a position in Haemonetics in Q2 2013 and held it in 11 quarters.
  • ClearBridge LLC (Maryland)'s Haemonetics position peaked at $6.82M in Q1 2015.
  • 171 funds tracked by Wall St. Rank held Haemonetics as of Q1 2016.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q1 2016, filed 16 May 2016.